GlassScriptPhysician profile
Janice R Driskell
NPI 1649756271
$6,472.15
in general payments reported to CMS, 2019-2025
21 companies · $835 in 2025
The $835 reported for 2025 was more than what 82% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,478 · 2022: $1,393 · 2023: $1,450 · 2024: $1,317 · 2025: $835.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,601.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,601.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,829.28 | 2021-2025 | |
| Amgen INC. | $1,486.71 | 2021-2025 | Enbrel, Otezla, Evenity |
| Pfizer INC. | $371.24 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $306.93 | 2021-2025 | |
| Janssen Biotech, INC. | $232.37 | 2022-2025 | Tremfya, Stelara, Remicade |
| Aurinia Pharma U.S., INC. | $214.35 | 2022-2025 | Lupkynis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $192.28 | 2021-2024 | Cyltezo, Ofev |
| Fresenius Kabi USA, LLC | $170.39 | 2023-2025 | Idacio, Tyenne |
| Ucb, INC. | $153.20 | 2021-2025 | Cimzia, Bimzelx |
| Ani Pharmaceuticals, INC. | $91.21 | 2023-2024 | Purified Cortrophin Gel |
| Genentech USA, INC. | $80.68 | 2021-2025 | Actemra, Gazyva |
| Lilly USA, LLC | $73.13 | 2021-2023 | Taltz |
| Astrazeneca Pharmaceuticals LP | $66.15 | 2021-2022 | |
| Sobi, INC | $65.91 | 2022-2023 | |
| Octapharma USA, INC. | $24.72 | 2025 | Octagam Immune Globulin (Human) |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $22.94 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $21.92 | 2023 | Orencia |
| Organon LLC | $20.59 | 2024 | |
| Glaxosmithkline, LLC. | $18.33 | 2021 | |
| Radius Health, INC. | $16.55 | 2021 | |
| Scilex Pharmaceuticals INC. | $13.27 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janice Driskell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.